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Abstract
Background: Little research to date has investigated the spectrum of bladder health in women, including both
bladder function and well-being. Therefore, we expanded our previous baseline analysis of bladder health in the
Boston Area Community Health (BACH) Survey to incorporate several additional measures of bladder-related
well-being collected at the 5-year follow-up interview, including one developed specifically for women.
Methods: At follow-up, participants reported their frequency of 15 lower urinary tract symptoms (LUTS),
degree of life impact from and thought related to urinary symptoms or pelvic/bladder pain/discomfort, and
perception of their bladder condition. Prevalence ratios were calculated by generalized linear models with
robust variance estimation, adjusting for LUTS risk factors and individual LUTS. The BACH Survey was
approved by the New England Research Institutes Institutional Review Board and all participants provided
written informed consent.
Results: Generally similar findings were observed in the 5-year cross-sectional analysis as at baseline, irre-
spective of how we categorized LUTS or measured bladder-related well-being. Approximately one in five
women (16.2%–18.0% of 2527 eligible women) reported no LUTS and no diminished bladder-related well-
being, the majority (55.8%–65.7%) reported some LUTS and/or diminished well-being, and a further one in five
(16.9%–26.6%) reported the maximum frequency, number, or degree of LUTS and/or diminished well-being.
Measures of storage function (urinating again after <2 hours, perceived frequency, nocturia, incontinence, and
urgency) and pain were independently associated with bladder-related well-being.
Conclusions: Our similar distribution of bladder health and consistent associations between LUTS and bladder-
related well-being across multiple measures of well-being, including a female-specific measure, lend confi-
dence to the concept of a bladder health spectrum and reinforce the bothersome nature of storage dysfunction
and pain.
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As the medical and public health research communitieshave increasingly adopted a more holistic view of
health,1 a growing number of fields have developed or re-
vised their definitions of organ-specific health to include not
only the absence of disease or infirmity but also the presence
of well-being and/or absence of disease risk factors.2,3 Con-
sistent with this trend, the Prevention of Lower Urinary Tract
Symptoms (PLUS) Research Consortium developed the fol-
lowing working research definition of bladder health: ‘‘A
complete state of physical, mental, and social well-being
related to bladder function and not merely the absence of
lower urinary tract symptoms (LUTS). Healthy bladder
function permits daily activities, adapts to short-term physi-
cal or environmental stressors, and allows optimal well-being
(e.g., travel, exercise, social, occupational, or other activi-
ties).’’4 The Consortium also applied this working research
definition to the three main bladder functions (‘‘storage,’’
‘‘emptying,’’ and ‘‘bioregulatory’’) and described unhealthy
characteristics of each function.5
To begin to inform and quantify the spectrum of this new
concept, we recently performed a secondary analysis of ex-
isting data from the baseline interview of the Boston Area
Community Health (BACH) Survey, taking advantage of its
extensive collection of information on LUTS and its rare,
universal collection of information on interference with ac-
tivities from urinary experiences in adult women. Although
these two sets of measures—LUTS and interference from
urinary experiences—do not capture all constructs described
in our working bladder health definition, we used these two
measures to begin to approximate the spectrum of bladder
health. In our previous analysis, we found that approximately
one in five women might be considered to have optimal
bladder health (no LUTS and no interference), three in five to
have good to intermediate health (intermediate frequencies of
LUTS or interference), and the remaining one in five to have
worse or poor bladder health (constant LUTS or interfer-
ence), supporting a spectrum of bladder health in women.6
We also found that measures of storage function, such as
urinary urgency and frequency, were independently associ-
ated with prevalent interference. However, each of these
findings was limited by its reliance on a measure of well-
being or bother (i.e., interference) developed for men with
benign prostatic hyperplasia (BPH) rather than for women.
Therefore, to determine the sensitivity of our findings to this
male- or BPH-specific measure, we repeated the analyses
(both for the cross-sectional distribution of bladder health and
associations between prevalent LUTS and bladder-related
well-being) using data from a female-specific measure of
well-being collected at the BACH follow-up interview. As
secondary objectives, we also repeated the analyses using
several additional single-item measures of well-being col-
lected at the follow-up interview to determine whether sim-
ilar findings could be generated with more brief measures.
Methods
Study population and design
The BACH survey is a population-based, longitudinal
study of community-dwelling residents from Boston
(n = 5506). Participants were recruited from 2002 to 2005
using a two-stage cluster design, with stratification by sex
(male and female), race/ethnicity (equally distributed across
black, Hispanic, and white), and age (30–39, 40–49, 50–59,
and 60–79 years; 63.4% completion rate). At baseline, con-
sented participants completed an in-home interview and
self-administered questionnaire (>2 hours), provided an
early-morning blood sample, and had their height, weight,
blood pressure, hip and waist circumference, pulse rate,
and blood pressure measured.7 Participants were recontacted
*5 years later for a follow-up visit in 2008–2010.
For this analysis, we limited the analytic sample to female
participants who completed the follow-up interview, as well
as at least one LUTS item, one item on the female-specific
well-being measure, and each single-item well-being mea-
sure collected at follow-up. For association analyses, women
were additionally required to provide complete information
on all covariates.
The BACH Survey was approved by the New England
Research Institutes Institutional Review Board and all par-
ticipants provided written informed consent.
LUTS assessment
At the follow-up interview, participants completed ques-
tions about their frequency of several measures of storage,
emptying, and bioregulatory function.5 These included
LUTS such as urgency, nocturia, and pain with bladder filling
to capture unhealthy storage; LUTS such as hesitancy, in-
complete emptying, and pain with urination to capture un-
healthy emptying; and urinary tract infections to capture
unhealthy bioregulatory function. As most of these measures
are symptoms, we refer to them hereafter as ‘‘LUTS’’ for
simplicity. LUTS were assessed by several validated ques-
tionnaires, including the American Urological Association
Symptom Index (AUASI),8 Sandvik Incontinence Severity
Scale,9 and Interstitial Cystitis Symptom Index,10 as well as
by items written specifically for BACH.
We collapsed the 26 LUTS items assessed into 15 com-
bined LUTS, as several used either similar wording or cap-
tured similar LUTS.6 For each combined LUTS, we used a
criterion of £20% disagreement across responses to combine
items (Appendix Table A1) and the maximum response from
any of the contributing items to capture LUTS frequency.
Missing values for individual LUTS items were assigned a
value of ‘‘none’’ (n = 707 participants had 1 missing item and
74 had 2–4 missing items). For analyses describing the
spectrum of bladder health, we used the full range of LUTS
frequency categories, whereas for analyses investigating
LUTS associated with well-being, we defined LUTS as a
frequency of ‘‘rarely’’ or more (vs. ‘‘none’’) to allow us to
explore the lower end of the LUTS frequency distribution
closest to what might represent optimal bladder health.
Well-being assessment
At the follow-up interview, bladder-related well-being or
bother was assessed in all women irrespective of LUTS by
five measures: the Incontinence Impact Questionnaire
(IIQ),11 three separate well-being related items, and the in-
terference with activities domain of the Epstein Quality of
Life Questionnaire for BPH.12 The first four scales/items
were assessed in all participants for the first time at follow-up,















































whereas the Epstein scale was also administered at baseline
and incorporated into our previous baseline analysis.6
The first scale, the IIQ, was developed and validated spe-
cifically for women with incontinence.11 It queries the degree
to which experiences with ‘‘urine leakage’’ affect seven daily
activities or aspects of life, including the ability to do
household chores, such as cooking, housecleaning, laundry,
or yard work; physical recreational activities, such as walk-
ing, swimming, or other exercise; entertainment activities,
such as going to a film or concert; the ability to travel by car
or bus for distances greater than 30 minutes away from home;
participation in social activities outside the home; and emo-
tional health. It also queries the degree to which urine leakage
causes participants to experience frustration. This scale was
modified for the BACH follow-up interview to expand ‘‘urine
leakage’’ to ‘‘urinary symptoms and pain or discomfort in
[their] pelvic or bladder area.’’
The three single-item measures of bladder-related well-
being were as follows: (1) ‘‘How much did you think about
your urinary symptoms and/or pelvic pain during the last
month?’’ (modified from the National Institutes of Health
Chronic Prostatitis Symptom Index13); (2) ‘‘If you were to
spend the rest of your life with your urinary and/or pelvic pain
condition the way it has been over the last month, how would
you feel about that?’’ (modified from the AUASI8); and (3)
‘‘Which of the following statements best describes your
bladder condition best at the moment?’’ (a validated item on
patients’ perception of their bladder condition developed for
individuals with overactive bladder14).
Finally, the Epstein scale, a scale developed and validated
for men with BPH,12 queries the frequency of interference
from urinary ‘‘problems’’ in the past month with five daytime
activities (drinking fluids before travel, driving for 2 hours
without stopping, going to places that may not have a toilet,
playing sports outdoors such as golf, and going to movies,
shows, and church), and two nighttime activities (drinking
fluids before bed and getting enough sleep at night). The
Epstein scale was modified for BACH to refer to urinary
‘‘problems’’ as ‘‘symptoms’’ and to include interference due
to pain or discomfort in the pelvic or bladder area.
For the IIQ and Epstein scale, missing values were as-
signed a value of ‘‘none’’ (n = 3 participants for the IIQ and 6
for the Epstein scale). Analyses describing the distribution of
bladder health used the full range of well-being categories,
whereas those investigating LUTS associated with well-
being dichotomized these variables as ‘‘none’’ or ‘‘never’’
versus any degree or frequency of impact/problems/inter-
ference to allow us to explore the lower end of the distribution
farthest away from symptomatic urologic disease and closest
to what might represent optimal bladder health.
Statistical analysis
To account for the BACH sampling design, we weighted
all observations inversely proportional to their probability of
selection, with further poststratification to the Boston popu-
lation using the 2000 US Census.7
Cross-sectional distribution of bladder health at follow-
up. Similar to our previous analysis of bladder health at
baseline,6 we used several approaches to explore and quan-
tify the cross-sectional distribution of bladder health at
follow-up. The first were cross-tabulations of the maximum
frequency of LUTS (out of 12 LUTS, using any incontinence
in the past year rather than individual types of incontinence in
the past week) or number of LUTS and the maximum degree
of life impact, using data from the IIQ. In these cross-
tabulations, we included women with self-reported past or
current bladder conditions (i.e., use of current LUTS medi-
cations, previous incontinence or bladder surgery, chronic
indwelling catheterization, and bladder cancer) in the highest
LUTS/impact category to acknowledge their poorer bladder
health and to avoid misclassifying them as having better
bladder health because of the influence of treatment on their
current self-reported LUTS and life impact.
Additional approaches used to describe the distribution of
bladder health were as follows: (1) a scatter plot of IIQ life
impact and LUTS frequency scores and (2) a histogram of a
combined life impact and LUTS frequency score. The life
impact score was calculated by summing the degree of im-
pact (0–3) with each of the five activities and two emotional
health items (range: 0–21).11 The LUTS frequency score was
calculated by summing the frequency (0–5, except for any
incontinence: 0–4) of the above-described 12 LUTS (range:
0–59) and then by standardizing to a range of 21. Finally, we
calculated a combined life impact and LUTS frequency score
by summing the individual life impact and LUTS scores
(range: 0–42).
In secondary analyses, we performed cross-tabulations of
the maximum frequency and number of LUTS with the
single-item measures of well-being.
Prevalent associations between LUTS and well-being.
To determine whether previously observed associations be-
tween prevalent LUTS and decreased well-being using the
Epstein interference scale at baseline6 could also be observed
using the female-specific IIQ scale, we examined the rela-
tionship between prevalent LUTS and well-being at follow-
up. Potential confounding was investigated by comparing
proportions of demographic, lifestyle, and clinical variables
by LUTS and well-being status at follow-up. Associations
were investigated by calculating crude and multivariable-
adjusted prevalence ratios, using log-link generalized linear
models with robust variance estimation. Our first set of
multivariable-adjusted models included terms for follow-up
age; race/ethnicity; menopausal status; parity; smoking sta-
tus; alcohol intake; health-related limitations in activities;
self-reported physician diagnoses of high blood pressure,
types I or II diabetes, cardiovascular disease, and arthritis;
depressive symptoms15; and measured body mass index and
waist circumference. Our second set included the afore-
mentioned variables, as well as all individual LUTS, to
identify those independently associated with diminished
well-being.
Secondary analyses repeated the analyses using the single-
item measures of well-being.
Sensitivity analyses. To ensure that any observed dif-
ference between our previous baseline findings6 and those
from this analysis was specific to the new scales/items rather
than to changes in the BACH population over time, we re-
peated all of the analyses using the 5-year follow-up Epstein
interference scale data (as opposed to the baseline data).
Additional sensitivity analyses for the cross-sectional bladder















































Table 1. Demographic, Lifestyle, and Clinical Characteristics of Women by Frequency of Lower Urinary
Tract Symptoms and Degree of Life Impact from Urinary Symptoms, Pain or Discomfort
in the Pelvic or Bladder Area; Boston Area Community Health Survey, 2008–2010
All participants
(N = 2527)








(N = 686) p
Age, years, %
26–44 32.5 42.9 30.0 34.0 27.7
45–64 42.1 42.4 42.1 <0.001 41.3 44.6 0.217
‡65 25.4 14.7 28.0 24.7 27.7
Race, %
Black 28.8 34.6 27.5 29.1 27.9
Hispanic 12.2 14.2 11.8 0.032 11.3 15.1 0.230
White 58.9 51.2 60.8 59.5 57.0
Menopausal status, %
Premenopausal/Undetermined 28.2 35.7 26.4 30.2 21.7
Perimenopausal 17.5 19.6 17.0 0.004 18.0 15.7 0.003
Postmenopausal 32.2 31.6 32.3 32.1 32.4
Surgical 22.2 13.1 24.3 19.6 30.2
Parity, %c
0 pregnancies 19.3 21.8 18.6 20.6 15.1
1–3 pregnancies 46.3 48.8 45.7 0.260 46.3 46.4 0.126
‡4 pregnancies 34.3 29.0 35.6 33.0 38.6
Cigarette smoking status, %
Never smoker 47.4 54.2 45.8 50.3 38.3
Former smoker 31.6 23.4 33.5 0.064 29.9 36.9 0.008
Current smoker 18.5 19.5 18.3 17.4 22.0
Alcohol use, average drinks/day, %c
<1 drink 39.6 42.7 38.8 37.3 46.6
1–2 drinks 45.2 40.8 46.3 0.450 47.8 36.9 0.019
‡3 drinks 11.2 12.3 10.9 11.3 10.9
Body mass index, kg/m2, %c
<25 27.5 29.5 27.0 31.2 15.6
25–29 30.7 33.6 30.0 0.559 31.1 29.2 <0.001
‡30 41.1 35.6 42.4 36.9 54.3
Waist circumference, cm, %c
<65 2.3 1.7 2.4 2.7 1.1
65–89 51.8 54.1 51.3 0.427 55.2 41.1 <0.001
90–114 36.3 37.6 36.0 34.9 41.0
‡115 9.2 6.6 9.8 7.0 16.0
Health-related limitations in activities, %d
Not limited at all 52.2 72.3 47.4 59.9 27.9
Limited a little 28.9 19.6 31.1 <0.001 26.7 35.7 <0.001
Limited a lot 18.9 8.1 21.5 13.3 36.5
Self-reported physician diagnosis of, %
High blood pressure 37.1 25.8 39.7 <0.001 34.5 45.3 0.002
Type I diabetes 4.1 3.1 4.3 0.333 2.5 8.9 <0.001
Type II diabetes 10.8 6.7 11.8 0.001 8.9 17.0 <0.001
Cardiovascular diseasee 27.1 19.8 28.8 0.006 24.9 34.1 0.004
Arthritis or rheumatism 41.5 24.8 45.5 <0.001 37.6 54.1 <0.001
Depressive symptoms, %f 17.0 7.4 19.3 <0.001 12.4 31.8 <0.001
All values were weighted according to the sampling weights of the Boston Area Community Health Survey.
aIncludes 15 LUTS in the past month (urinating again after <2 hours; perceived frequency; nocturia; stress incontinence [in the past
week]; urgency incontinence [in the past week]; nonstress, nonurgency incontinence [in the past week]; any incontinence [in the past year];
dribbling/wet clothes after urination; urgency/difficulty postponing urination; pain, burning, discomfort in the pubic/bladder area;
straining/difficult to begin voiding; weak stream; intermittency; incomplete emptying; and urinary tract infection [in the past year]).
‘‘None’’ was defined as no LUTS in the past month and ‘‘ever’’ was defined as any LUTS experienced at least rarely in the past month.
bAssessed by a modified version of the IIQ. ‘‘None’’ was defined as no impact with any of the seven activities/aspects of life assessed and
‘‘any’’ was defined as at least slight impact with any activity/aspect of life.
cNumbers may not sum to 100% because of missing values.
dExamples for participants included moving a table, pushing a vacuum cleaner, softball, or playing golf.
eIncludes coronary artery bypass, myocardial infarction, arrhythmia, congestive heart failure, transient ischemic attack, stroke, carotid
artery surgery, intermittent claudication, pulmonary embolus, aortic aneurysm, heart rhythm disturbance, Raynaud’s disease, and peripheral
vascular disease.
fDefined as an affirmative response to at least five of eight items on a revised version of the Center for Epidemiologic Studies of
Depression Scale.15
















































health distribution analysis were as follows: (1) exclusion of
women with known past or current bladder conditions (i.e.,
current LUTS medications, previous incontinence or bladder
surgery, chronic indwelling catheterization, and bladder
cancer), as their exact position on the LUTS/well-being dis-
tribution could not be determined based on their untreated
LUTS/well-being; and (2) exclusion of women with non-
bladder conditions that might contribute to LUTS or dimin-
ished well-being due to urinary symptoms or pelvic/bladder
pain or discomfort (i.e., genitourinary cancers besides blad-
der cancer, prolapse of the uterus, ‘‘bladder, or rectum,’’
congenital urinary tract abnormalities [a large proportion of
which are renal16,17], endometriosis, pelvic inflammatory
disease, chronic pelvic pain, vulvodynia, and diabetes).
These women were excluded because their LUTS and di-
minished well-being might not reflect poor bladder health,
but instead poor health in other organs besides the bladder.
For analyses investigating LUTS associated with well-being,
sensitivity analyses were as follows: (1) exclusion of women
with histories of bladder and non-bladder-related conditions
potentially associated with LUTS and/or well-being and (2)
use of higher cutoff points for LUTS (at least ‘‘a few times’’)
and well-being (at least ‘‘moderate’’) to determine whether
associations observed at lower ends of the LUTS and well-
being spectrums were also observed at higher ends. Analyses
were performed using R v3.5.18–20
Results
Distribution of bladder health at follow-up
Of the 3205 female participants interviewed at baseline,
2534 were interviewed *5 years later at the follow-up in-
terview, and 2527 provided information on at least one
LUTS, one IIQ item, and each single-item well-being mea-
sure. These 2527 women were similar to those in our previ-
ous baseline bladder health distribution analyses,6 with the
majority being perimenopausal or postmenopausal, parous,
overweight, or obese, and not limited in activities by their
health (Table 1). Eighty-one percent of women reported
LUTS at least rarely and 23.9% reported at least slight
bladder-related, diminished well-being. When compared by
LUTS and well-being status, women with LUTS or dimin-
ished well-being tended to be older, have undergone surgical
menopause, be former smokers, and have limitations in their
activities and self-reported comorbidities, including high
blood pressure, diabetes, cardiovascular disease, arthritis,
and depressive symptoms. Women with LUTS also tended to
be non-Hispanic white, and women with diminished well-
being were less likely to consume alcohol and more likely to
be obese and have a large waist circumference.
With respect to LUTS, a similar distribution was observed
at the follow-up interview as at baseline: 19.3% of women
reported never experiencing LUTS, 61.4% rarely to usually,
Table 2. Frequency of Lower Urinary Tract Symptoms in the Past Month in a Community-Based
Sample of 2527 Women; Boston Area Community Health Survey, 2008–2010








Urinating again after <2 hours 43.1 13.9 19.2 12.8 4.2 6.7 56.8
Perceived frequency 62.6 6.9 10.5 9.1 4.0 6.9 37.4
Nocturia 58.0 11.2 10.8 5.1 3.7 11.2 42.0
Stress incontinenceb 89.4 2.7 3.9 2.8 0.6 0.7 10.7
Urgency incontinenceb 91.3 3.3 2.9 1.1 0.9 0.5 8.7
Nonstress, nonurgency incontinenceb 93.4 1.6 2.9 1.2 0.3 0.5 6.5
Dribbling/wet clothes after urination 82.2 7.9 5.1 2.5 0.5 1.7 17.7
Urgency/difficulty postponing urination 63.3 11.9 10.4 6.6 2.4 5.4 36.7
Pain, burning, discomfort in the pubic/bladder area 88.1 3.8 3.4 1.5 1.7 1.4 11.8
Straining/difficult to begin voiding 90.8 3.4 3.4 1.0 0.2 1.2 9.2
Weak stream 86.9 5.7 4.1 1.4 0.7 1.2 13.1
Intermittency 83.8 6.3 4.2 2.6 2.1 1.0 16.2
Incomplete emptying 70.2 10.1 13.4 3.6 1.2 1.4 29.7
Any incontinencec
Degree in the past year
None Mild Moderate Severe Very severe Any
66.1 18.4 11.7 2.2 1.5 33.8
Number in the past year
0 1 2–3 4–5 6–7 ‡8 Any
Urinary tract infectiond 89.5 7.2 2.7 0.3 0.2 0.1 10.5
Any LUTS 19.3 14.7 23.9 15.0 7.8 19.2 80.6
aAll values were weighted according to the sampling weights of the Boston Area Community Health Survey.
bAssessed in the past week and categorized into the following frequencies: 0, 1, 2–3, 4–5, 6–7, and ‡8 times.
cAssessed in the past year and categorized into the following groups: none, mild, moderate, severe, and very severe, according to methods
described previously.22
dAssessed in the past year and categorized into the following frequencies: 0, 1, 2–3, 4–5, 6–7, and ‡8 times.















































and 19.2% almost always, for a total of 80.6% with any
frequency of LUTS in the past month (Table 2). With respect
to well-being, the degree of impact reported on the IIQ was
slightly less than that the frequency of interference reported
on the Epstein scale at baseline (and follow-up): 76.2% re-
ported no impact at all, 18.4% slight to moderate impact, and
5.5% great impact, for a total of 23.9% with any degree of
impact (Table 3). This distribution was generally similar
across each of the different life impact domains. When other
single-item measures of well-being were examined, 32.2%
reported thinking about their urinary symptoms or pelvic pain
at least ‘‘a little’’ of the time, 65.3% felt ‘‘pleased’’ or less
than pleased about their current urinary and/or pelvic pain
condition (47.4% using a threshold of ‘‘mostly satisfied’’),
and 40.8% reported at least ‘‘very minor’’ problems with
their bladder condition (22.0% using a threshold of ‘‘minor’’
problems). Overall, high agreement was observed between
measures of well-being (% agreement = 63.1%–76.8%).
When we cross-classified LUTS and bladder-related well-
being as assessed by the IIQ, the joint distribution of these
two measures was similar to that observed at baseline (and
follow-up) using the Epstein interference scale: 18.0% re-
ported no LUTS and no impact, 34.9% reported LUTS rarely
or a few times and/or slight impact, 20.9% reported LUTS
fairly often or usually and/or moderate impact, and 26.3%
reported LUTS almost always and/or great impact, with 3.8%
reporting both (Fig. 1 and Appendix Table A3). Eight percent
(7.5%) of women were classified in the highest category
because of their current or past bladder conditions. Interest-
ingly, the largest subgroup within each of these groups was
always the group with LUTS, but without impact (combined
prevalence = 52.9%), similar to our observation at baseline.
Table 3. Degree of Life Impact from Urinary Symptoms, Pain or Discomfort in the Pelvic or Bladder Area
in a Community-Based Sample of 2527 Women; Boston Area Community Health Survey, 2008–2010
Activity/aspect of life
Degree of life impact (IIQ), %a
Not at all Slight Moderate Great Any
Ability to do household chores 91.5 5.1 2.7 0.7 8.5
Physical recreational activities 88.6 6.8 2.7 1.9 11.4
Entertainment activities 89.8 5.5 2.4 2.2 10.1
Ability to travel by car or bus for >30 minutes 86.2 7.3 3.2 3.2 13.7
Participation in social activities outside of home 89.6 4.7 4.0 1.7 10.4
Emotional health 89.4 6.0 2.9 1.6 10.5
Experience frustration 84.7 8.8 3.5 2.9 15.2
Any impact 76.2 12.3 6.1 5.5 23.9
Degree of thought, %a
None Only a little Some A lot Any
67.9 19.4 8.0 4.8 32.2





dissatisfied Un-happy Terrible Any
34.7 17.9 20.8 13.9 7.4 2.3 3.0 65.3
Patients’ perception of bladder condition (% with a problem)a
No Very minor Minor Moderate Severe Many severe Any
59.2 18.8 12.1 7.0 1.6 1.3 40.8
Activity
Frequency of interference in the past month (Epstein scale), %a
None A little Some Most All Any
Drinking fluids before travel 78.2 8.8 4.5 3.7 4.8 21.8
Driving for 2 hours without stopping 82.6 6.4 3.8 3.5 3.7 17.4
Going to places that may not have a toilet 76.2 8.2 6.1 3.6 5.8 23.7
Playing sports outdoors such as golf 93.4 2.3 1.5 0.7 2.0 6.5
Going to movies, shows, church, etc. 90.0 3.5 2.9 1.7 1.9 10.0
Drinking fluids before bed 74.5 10.1 6.8 3.3 5.3 25.5
Getting enough sleep at night 76.1 9.5 5.9 4.1 4.4 23.9
Interference with any activity 57.5 14.3 10.1 7.4 10.7 42.5
aAll values were weighted according to the sampling weights of the Boston Area Community Health Survey.
AUASI, American Urological Association Symptom Index.















































Generally similar distributions were also observed when the
number of LUTS was examined rather than the maximum
frequency of LUTS (18.0% no LUTS or impact, 63.8% some
LUTS or impact, and 18.2% ‡ 8 LUTS or the worst degree of
impact). Results shifted slightly more toward lower LUTS
frequencies and impact when women with bladder conditions
and those who might contribute to bladder symptoms were
excluded and when younger women were examined (data not
shown and Appendix Table A2). Finally, when we investi-
gated LUTS and life impact as continuous scores, a greater
density of values was observed at the lower ends of the LUTS
and life impact distributions, and a right-skewed distribution
was observed when the LUTS and life impact scores were
summed.
Similar distributions of bladder health were observed when
we explored single-item measures of well-being as when we
included the IIQ (using the maximum frequency of LUTS:
16.2%–17.7% no LUTS or impact, 56.6%–57.8% some
LUTS or impact, and 24.7%–26.6% LUTS almost always
and the worst degree of impact; and using the number of
LUTS: 16.2%–17.7%, 64.3%–65.7%, and 16.9%–18.7%,
respectively; Appendix Table A3).
Prevalent LUTS associated with well-being
In analyses investigating LUTS associated with well-
being, we observed generally similar findings using the IIQ
as in our previous baseline analysis using the Epstein inter-
ference scale. Specifically, we found that several measures
of storage function (urinating again after <2 hours, per-
ceived frequency, nocturia, urgency and any incontinence,
and urgency), pain in the pubic/bladder area, and incomplete
FIG. 1. Joint distribution1 of LUTS in the past month and degree of impact from urinary symptoms, pain or discomfort in
the pelvic or bladder area in a community-based sample of 2527 women; Boston Area Community Health Survey, 2008–
2010. 1All values were weighted according to the sampling weights of the Boston Area Community Health Survey.
2Maximum frequency of LUTS across 12 LUTS (urinating again after <2 hours; perceived frequency; nocturia; any
incontinence [in the past year]; dribbling/wet clothes after urination; urgency/difficulty postponing urination; pain, burning,
discomfort in the pubic/bladder area; straining/difficult to begin voiding; weak stream; intermittency; incomplete emptying;
and urinary tract infection [in the past year]). 3Number of LUTS experienced at least rarely in the past month (out of the 12
LUTS described above). 4Maximum degree of impact across seven activities or aspects of life. 5Represents the percentage
of women who reported the highest category of LUTS and impact. 6Represents the percentage of women with self-reported
current or past bladder conditions (i.e., use of current LUTS medications, previous incontinence or bladder surgery, chronic
indwelling catheterization, or bladder cancer). 7Calculated by summing the degree of life impact (0–3) with each of the five
activities and two emotional health items (range: 0–21). 8Calculated by summing the frequency (0–5, except for inconti-
nence in the past year = 0–4) of 12 LUTS (range: 0–59) and then multiplying by 21/59 to obtain the same range as the
impact score (range: 0–21). 9Calculated as the sum of the LUTS and life impact scores (range: 0–42). IIQ, Incontinence
Impact Questionnaire; LUTS, lower urinary tract symptom.












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































emptying were independently, positively associated with
prevalent life impact (Table 4). In addition, straining to begin
urination was inversely associated with prevalent impact, and
stress and nonstress/nonurgency incontinence were posi-
tively associated with impact. Each of these new associations
was specific to use of the IIQ rather than the Epstein in-
terference scale, except for positive findings for stress in-
continence; these new findings were related to slight changes
in the analytic sample at follow-up, as they were also ob-
served when the analyses were repeated using the Epstein
scale at follow-up (Appendix Table A4). Similar findings
were also observed in sensitivity analyses excluding women
with known bladder conditions, as well as non-bladder con-
ditions that might contribute to LUTS or pain/discomfort
in the pubic area. Finally, positive associations persisted
for perceived frequency, all types of incontinence, and pain
when we increased the thresholds for LUTS and impact,
whereas those for other LUTS did not (data not shown).
In analyses investigating each of the other single-item
measures of well-being, generally similar findings were ob-
served as for the IIQ, at least with respect to measures of
storage function (urinating again after <2 hours, perceived
frequency, nocturia, all types of incontinence, and urgency)
and pain. Findings were less consistent for measures of
emptying function (straining to begin voiding and incomplete
emptying; Appendix Table A4).
Discussion
In this large, regionally representative analysis of bladder
health in adult American women, we observed generally
similar findings as in our previous analysis of bladder health
that was limited to a well-being measure (i.e., interference
scale) developed for men with BPH. Specifically, in this
analysis, we observed that approximately one in five women
might be considered to have optimal bladder health (i.e., no
LUTS or diminished well-being; 16.2%–18.0%), three in five
to have intermediate bladder health (i.e., some LUTS or di-
minished well-being; 55.8%–65.7%), and one in five to have
poor bladder health (i.e., the maximum frequency, number, or
degree of LUTS or diminished well-being; 16.9%–26.6%).
These findings were observed irrespective of how we clas-
sified LUTS or assessed well-being. We also observed a
right-skewed bladder health distribution when we modeled
bladder health as a continuous score, indicating a greater
density of scores at the lower end of the LUTS/well-being
continuum. Finally, measures of storage dysfunction and pain
tended to be independently associated with diminished well-
being.
In addition to the consistency of our distributions of
bladder health across all five well-being measures included
in BACH, our estimates are also similar to those calculated
in the Epidemiology of LUTS (EpiLUTS) study, the only
other study, to our knowledge, to have published data on
the joint distribution of LUTS and bladder-related well-being
in women unselected for LUTS.21 In that multinational,
population-based study of American, British, and Swedish
women, 19.9%–21.3% of women ‡40 years of age reported
no LUTS (using a cutoff point of ‘‘sometimes’’), no problems
with urinary symptoms, and/or being ‘‘delighted’’ or
‘‘pleased’’ with their current urinary symptoms; 51.0%–
52.1% reported one to two types of LUTS (storage, voiding,
or postmicturition), ‘‘some very minor’’ to ‘‘moderate’’
problems, and/or being ‘‘mostly satisfied’’ to ‘‘mostly dis-
satisfied’’ with their current symptoms; and 26.6%–29.1%
reported three types of LUTS, ‘‘severe’’ to ‘‘many severe’’
problems, and/or feeling ‘‘unhappy’’ to ‘‘terribly’’ about their
symptoms. These analyses used the same well-being measures
as in our analysis (AUASI and bladder condition perception
items), but a different categorization of LUTS (0, 1, 2, or 3
types of LUTS; all estimates calculated from Ref. 21).
We believe the similarity of these values to our estimates
(16.2%–18.0%, 55.8%–65.7%, and 16.9%–26.6%, respec-
tively) lends confidence to the overall concept of a spec-
trum of bladder health, as it does not appear to depend on
study population (Boston area vs. entire United States, United
Kingdom, and Sweden), method of categorizing LUTS
(maximum frequency, type, or number), or type and length
of bladder-related well-being or bother measures (degree of
life impact, degree of thought, perception of bladder condi-
tion, and frequency of interference). Furthermore, our find-
ings suggest that even brief and non-sex-specific measures of
well-being may be sufficient to estimate crude distributions
of bladder health. More refined measures will still, however,
be necessary to estimate accurate distributions, taking into
account other aspects of bladder health, such as adaptation to
short-term stressors.4
With respect to LUTS associated with diminished well-
being, we observed generally similar findings as in our pre-
vious baseline analysis using the Epstein interference scale,6
as well as in the EpiLUTS study.21 Specifically, each of
these analyses observed that several individual measures of
storage function (or dysfunction, e.g., frequency, perceived
frequency, nocturia, and urgency incontinence) were inde-
pendently associated with decreased well-being. These
findings suggest that symptoms that are difficult to defer (i.e.,
frequent or urgent urination) tend to contribute to greater
diminished well-being than those related to voiding once it
has begun.
In summary, our similar findings to those from our previ-
ous baseline analysis of bladder health in the BACH Survey,
as well as to those in the EpiLUTS Study, lend confidence
to the overall concept of a spectrum of bladder health and
reinforce the bothersome nature of storage dysfunction and
pain. Future studies should investigate the distribution of
bladder health in additional populations using more refined
bladder health-specific measures, as well as the distribution
of changes in bladder health over time to help support bladder
health promotion and LUTS prevention efforts in women.
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Appendix Table A1. Lower Urinary Tract Symptoms Assessed in the Boston Area Community
Health Survey at baseline and 5 Years Later at Follow-Up, 2002–2010
Items collected in the BACH Survey Collapsed items
Number of times you accidentally leaked urine without any particular
physical activity or warning in the past 7 days
Nonstress, nonurgency incontinence in the
past week
Number of bladder infections in the past yeara Urinary tract infection in the past year
Number of kidney infections in the past yeara
Push or strain to begin urination in the past monthb Straining/difficult to begin voiding
Difficulty starting to urinate in the past monthb
Pain or burning during urination in the past monthc Pain, burning, discomfort in the
pubic/bladder area in the past monthPain, burning, discomfort, or pressure in your pubic or bladder area in the
past monthc
Pain or discomfort in your urethra in the past monthc
Pain increasing when your bladder fills in the past monthc
Pain relieved by urination in the past monthc
Weak urinary stream in the past month Weak stream in the past month
Number of times you accidentally leaked urine when you had the strong
feeling that you needed to empty your bladder but you could not get to
the toilet fast enough in the past 7 days
Urgency incontinence in the past week
Baseline: Dribbling after urination in the past monthd Dribbling/wet clothes after urination in
the past monthFollow-up: Urine leakage almost immediately after you have finished
urinating and walked away from the toilet in the past month?e
Follow-up: A prolonged trickle or dribble at the end of your urine flow in
the past month?e
Baseline: Wet clothes because of dribbling after urination in the past
monthd
Stop and start again several times while you urinate in the past month Intermittency in the past month
Number of times you accidentally leaked urine when you were performing
some physical activity such as coughing, sneezing, lifting, or exercise, in
the past 7 days
Stress incontinence in the past week
Sensation of not emptying your bladder completely after you have finished
urinating in the past month
Incomplete emptying in the past month
Leaked even a small amount of urine in the past 12 months, including
frequency and amount
Any incontinence in the past year
(continued)
















































Items collected in the BACH Survey Collapsed items
Difficulty postponing urination in the past monthf Urgency/difficulty postponing urination in
the past monthStrong urge or pressure to urinate immediately, with no, or little warning in
the past monthf
Get up to urinate more than once during the night in the past month Nocturia in the past month
Frequent urination during the day in the past monthg Perceived frequency in the past month
Urinate again less than 2 hours after you finished urinating in the past
monthg
Urinating again after <2 hours in the past
month (frequency)
Strong urge or pressure that signaled the need to urinate immediately,
whether or not you urinated or leaked urine in the past 7 days
—h
aPercent disagreement at baseline (comparing those without a particular LUTS to those who reported experiencing it at least
rarely) = 7.2%.
bPercent disagreement at baseline = 6.2%.
cPercent disagreement at baseline = 4.3%–7.9%.
dPercent disagreement at baseline = 5.8%.
ePercent disagreement at follow-up = 14.7%.
fPercent disagreement at baseline = 18.9%.
gPercent disagreement at baseline = 25.8%.
hNot included in the analysis.
BACH, Boston Area Community Health Survey; LUTS, lower urinary tract symptom.
Appendix Table A2. Joint Distribution of Prevalent Lower Urinary Tract Symptoms in the Past Month
and Degree of Impact from Urinary Symptoms, Pain or Discomfort in the Pelvic or Bladder Area
in Women by Age Group; Boston Area Community Health Survey, 2008–2010
Frequency of LUTS,a %
No symptoms Rarely A few times Fairly often Usually Almost always
26–44 years of age
Degree of life impact (IIQ)b
Not at all 23.8 15.8 18.1 9.9 5.2 3.9
Slight 0.6 0.4 4.3 2.8 2.0 1.7
Moderate 0.0 0.2 0.9 0.3 0.1 1.2
Great 0.0 0.0 0.2 0.4 0.8 2.8c/4.5d
45–64 years of age
Degree of life impact (IIQ)b
Not at all 18.0 12.7 16.7 9.3 3.8 9.3
Slight 0.3 0.9 1.9 2.9 1.4 3.5
Moderate 0.2 0.0 1.2 1.0 0.4 3.2
Great 0.0 0.0 0.1 1.0 0.6 4.1c/7.5d
‡65 years of age
Degree of life impact (IIQ)b
Not at all 10.6 10.6 19.5 10.1 4.4 10.4
Slight 0.0 0.7 2.7 2.7 0.5 4.1
Moderate 0.0 0.4 1.5 1.2 0.4 2.9
Great 0.3 0.0 0.1 0.8 0.1 4.3c/11.6d
All values were weighted according to the sampling weights of the Boston Area Community Health Survey.
aMaximum frequency of LUTS across 12 LUTS (urinating again after <2 hours; perceived frequency; nocturia; any incontinence [in the
past year]; dribbling/wet clothes after urination; urgency/difficulty postponing urination; pain, burning, discomfort in the pubic/bladder
area; straining/difficult to begin voiding; weak stream; intermittency; incomplete emptying; and urinary tract infection [in the past year]).
bMaximum degree of impact across seven activities or aspects of life.
cRepresents the percentage of women who reported the highest category of LUTS and impact.
dRepresents the percentage of women with self-reported current or past bladder conditions (i.e., use of current LUTS medications,
previous incontinence or bladder surgery, chronic indwelling catheterization, or bladder cancer).
IIQ, Incontinence Impact Questionnaire.
(Appendix continues/)















































Appendix Table A3. Joint Distribution of Lower Urinary Tract Symptoms in the Past Month
and Well-Being Related to Urinary, Bladder, and/or Pelvic Pain Symptoms/Condition
in a Community-Based Sample of 2527 Women; Boston Area Community Health Survey, 2008–2010








always 0 1 2–3 4–7 8–12
Degree of thought, %
None 17.7 11.7 16.5 8.6 3.6 5.5 17.7 14.6 17.6 12.1 1.5
Only a little 0.5 2.1 4.4 3.4 1.8 5.1 0.5 1.9 3.6 9.0 2.4
Some 0.3 0.2 1.2 1.7 0.6 2.7 0.3 0.3 0.9 3.5 1.7
A lot 0.0 0.0 0.0 0.4 0.6 3.5c/7.9d 0.0 0.0 0.0 2.2 2.4c/7.8d
Degree of life impact (AUASI), %
Delighted 13.5 6.3 7.2 2.9 1.6 1.3 13.5 8.5 7.7 3.0 0.1
Pleased 2.7 4.0 5.0 2.5 0.7 2.1 2.7 4.6 5.0 3.9 0.9
Mostly satisfied 1.8 2.6 6.8 3.2 1.0 3.3 1.8 2.7 6.0 7.0 1.2
Mixed 0.4 0.9 2.0 3.6 1.6 4.0 0.4 0.8 2.4 7.4 1.5
Mostly dissatisfied 0.0 0.2 0.8 1.3 0.8 2.9 0.0 0.2 0.6 3.0 2.2
Unhappy 0.0 0.0 0.1 0.3 0.5 1.2 0.0 0.0 0.1 1.2 0.7
Terrible 0.0 0.0 0.2 0.2 0.5 1.9c/8.1d 0.0 0.0 0.3 1.3 1.1c/8.1d
Patients’ perceptions of bladder condition, %
No problems 17.1 10.8 14.6 6.6 2.8 3.6 17.1 12.8 15.1 9.8 0.7
Some very minor
problems
0.8 2.5 5.6 4.0 1.5 3.5 0.8 3.0 4.7 7.7 1.7
Some minor problems 0.2 0.5 1.4 2.6 1.7 3.9 0.2 0.7 1.6 5.5 2.2
Some moderate
problems
0.3 0.1 0.5 0.8 0.5 3.5 0.3 0.3 0.5 2.7 1.9
Severe problems 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.4 0.3
Many severe problems 0.0 0.0 0.0 0.0 0.0 1.2c/8.3d 0.0 0.0 0.0 0.7 0.6c/8.3d
Frequency of interference (Epstein scale), %
None 17.3 11.1 13.1 5.5 2.5 4.2 17.3 13.8 14.3 7.9 0.5
A little 0.7 1.8 4.7 3.1 1.0 1.9 0.7 1.5 3.6 6.5 0.9
Some 0.1 0.7 2.6 2.8 0.7 2.1 0.1 0.9 1.6 4.2 2.3
Most 0.2 0.2 1.0 1.0 1.7 2.5 0.2 0.3 1.3 3.7 1.2
All 0.2 0.1 0.7 1.7 0.7 6.9c/7.0d 0.2 0.3 1.4 4.7 3.2c/7.5d
All values were weighted according to the sampling weights of the Boston Area Community Health Survey.
aMaximum frequency of LUTS across 12 LUTS (urinating again after <2 hours; perceived frequency; nocturia; any incontinence [in the
past year]; dribbling/wet clothes after urination; urgency/difficulty postponing urination; pain, burning, discomfort in the pubic/bladder
area; straining/difficult to begin voiding; weak stream; intermittency; incomplete emptying; and urinary tract infection [in the past year]).
bNumber of LUTS experienced at least rarely in the past month (out of the 12 LUTS described above).
cRepresents the percentage of women who reported the highest category (or categories) of LUTS and diminished well-being.
dRepresents the percentage of women with self-reported current or past bladder conditions (i.e., use of current LUTS medications,
previous incontinence or bladder surgery, chronic indwelling catheterization, or bladder cancer).
AUASI, American Urological Association Symptom Index.
(Appendix continues/)
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